The synthesis of [3H]cadralazine of high specific activity
✍ Scribed by Derek E. Brundish; Peter D. Kane
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 350 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
The title compound has been prepared by two different approaches. The first involved a five-stage "hot" synthesis.where the tritiation step was selective debromination of a cyclic Fbromo-a-&unsaturated ketone. double bond was protected by formal aromatisation. this intermediate was determined by product. Cadralazine was also labelled in its side chain by reduction of the appropriate ketone with high specific activity sodium borotritide. labelled products had specific activities of 18 Ci/mmol and radiochemical purities of 90-96%. The The absolute structure of 3 H-PTNHR spectroscopy of its reduction Both
📜 SIMILAR VOLUMES
The antidepressant alaproclate (IJ i s a selective i n h i b i t o r o f neuronal serotonin reuptake w i t h 1 ow aff i n i t y f o r other receptor sites. (2, 2-( [ 2,5-3H2]-4-chl orophenyl)-2-methyl-2-propyl 2-aminopropanoate) with high specific a c t i v i t y (38 C i / m o l ) was prepared by h
## Abstract 4‐Hydroxy‐3‐[3‐oxo‐1‐(3‐bromophenyl)butyl]‐2H‐1‐benzopyran‐2‐one (3′ ‐bromowarfarin) was synthesized and resolved into its enantiomers by formation of the __d__‐10‐camphorsulfonate diastereoisomers, which were separated by liquid chromatography and hydrolyzed. The pure enantiomers were
Tritium labelling of buprenorphine, a mixed agonist-antagonist opioid ligand, was performed with a specific activity of 2.35 TBq/mmol (63.6 Ci/mrnol) starting with 15,16-didehydrobuprenorphine. Labels at positions 15 and 16 of the morphine skeleton proved to be sufficiently stable under strong acidi